The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects (Q72992790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

fluticasone propionate

1 reference

W C Howland

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

F C Hampel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

B G Martin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P H Ratner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J H van Bavel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E A Field

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

1106-1117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

Steroid-induced Reduction of Histamine Release Does Not Alter the Clinical Nasal Response to Cold, Dry Air

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

Activation of guinea pig lymphocytes and mast cells by grain-dust extract

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis. Evidence for a topical effect

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

The human pharmacology of fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980065-8

7 January 2021

10.1016/S0149-2918(96)80065-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9001827%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference